Opko Health Stock Is Climbing: What's Going On?
Opko Health Stock Is Climbing: What's Going On?
"We believe OPKO's shares are significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO's strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability," said Opko Health, Inc. (NASDAQ:OPK) shares are trading higher Thursday after the company announced a $100 million share repurchase program.
Opko健康股份有限公司（納斯達克證券交易所：OPK）股價在週四上漲，公司宣佈了一項1億美元的股票回購計劃。
The Details:
細節：
Opko said it expects to fund the repurchase program from existing cash and cash equivalents, and future cash flows. The company had approximately 697 million shares outstanding as of June 30, 2024, and the new authorization represents approximately 10.1% of shares outstanding at the current stock price.
Opko表示，它預計將從現有的現金及現金等價物和未來現金流中資助回購計劃。截至2024年6月30日，公司已經發行約6970萬股，新獲授權回購的股份約佔當前股價的10.1%。
"We believe OPKO's shares are significantly undervalued and offer an attractive investment opportunity. Buying back shares supports our conviction in OPKO's strategy as we continue to advance our pipeline in the clinic and streamline our diagnostic segment on a path to profitability," said Phillip Frost, M.D., CEO of Opko Health.
Opko健康公司的首席執行官菲利普·弗羅斯特博士（Phillip Frost, M.D.）表示：“我們認爲Opko的股份被嚴重低估並提供了極具吸引力的投資機會。回購股份支持我們對Opko策略的信心，我們將繼續在診所推動我們的管線並使我們的診斷部門走上盈利的道路。”
Additionally, Opko announced a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) after the market close Wednesday. Opko said the purchase agreement is secured by its profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA, a once-weekly treatment to treat pediatric growth hormone deficiency.
此外，Opko在週三收市後宣佈，與HealthCare Royalty（HCRx）簽訂了一項2500萬美元的非稀釋性票據購買協議。Opko表示，購買協議由其從輝瑞收到的利潤分成付款擔保，該付款與NGENLA許可協議有關，該協議是一種處理兒童生長激素缺乏症的每週一次治療方案。
According to data from Benzinga Pro, Opko Health shares are moving on heavy volume and are trading above the stock's 50-day moving average of $1.31.
根據Benzinga Pro的數據，Opko Health股價正在上漲並在高成交量中交易，高於該股票的50日移動平均線1.31美元。
Should I Sell My OPK Stock?
我應該賣掉我的Opko健康股票嗎？
When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.
在決定持有或出售股票時，投資者應考慮他們的投資期限、未實現收益和總回報。
Shares of Opko Health have decreased by 27.39% in the past year. An investor who bought shares of Opko Health at the beginning of the year would take a loss of $0.03 per share if they sold it today. The stock has risen 24.15% over the past month, meaning an investor who bought shares on June 1 would see a capital gain of $0.12.
過去一年中，Opko Health股價下跌了27.39%。如果投資者在年初購買了Opko Health股票並在今天出售，他們將每股虧損0.03美元。過去一個月，該股上漲了24.15%，這意味着在6月1日購買股票的投資者將獲得0.12美元的資本收益。
Opko Health shares have an all-time high of $5.15, representing 234.55% upside from current levels.
Opko Health股價有最高紀錄的5.15美元，目前爲234.55%的上漲潛力。
Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. Opko Health stock currently has an RSI of 84.21, indicating overbought conditions.
投資者還可以考慮市場動態。相對強度指數可用於指示股票是否超買或超賣。Opko Health股票目前的RSI爲84.21，表示超買條件。
For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.
如需高級圖表和分析工具以及股票數據，請訪問Benzinga Pro。免費試用。
OPK Price Action: According to Benzinga Pro, Opko Health shares are up 3.87% at $1.47 at the time of publication Thursday.
根據Benzinga Pro的數據，Opko Health股價在週四發佈時上漲了3.87%，爲每股1.47美元。
Read Also:
閱讀更多：
- What Happened With Intel Stock Today?
- 英特爾股票今天發生了什麼事？
Image: Shutterstock
圖片：shutterstock
